Online citations, reference lists, and bibliographies.
← Back to Search

Psychological Functioning Before And After Treatment Of Torticollis With Botulinum Toxin.

M. Jahanshahi, C. Marsden
Published 1992 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The impact of botulinum toxin injection on psychological function was assessed in 26 patients with idiopathic torticollis. Eighty five per cent of the patients and 88% of the relatives considered torticollis to be better following the injections. Symptomatic improvement with the injections was associated with significant reduction of depression and disability, but non-significant improvement in body concept, and self-esteem. This concordant pattern of change in symptoms and psychological function with the injections supports the proposal that in torticollis depression and disability are consequences of the postural abnormality of the head.
This paper references
A longitudinal study of depression , disability and body concept in torticollis
M Jahanshahi (1990)
10.1111/J.2044-8260.1988.TB00750.X
Cognitive style and depression: symptom-related, event-related or independent provoking factor?
G. Parry (1988)
10.1017/S0033291700009855
Depression in torticollis: a controlled study.
M. Jahanshahi (1988)
10.1212/WNL.39.1.80
Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis
D. Gelb (1989)
10.1016/0022-3999(91)90044-O
Psychosocial factors and depression in torticollis.
M. Jahanshahi (1991)
10.1016/S0140-6736(86)92070-2
DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS
J. C. Tsui (1986)
10.1177/003803856900300250
Society and the Adolescent Self-Image
D. J. Lee (1969)
Body concept , depression and disability in spasmodic torticollis
M Jahanshahi (1990)
This work was supported by a grant from the Medical Research Council
10.1136/jnnp.51.7.920
Botulinum toxin in spasmodic torticollis.
R. Stell (1988)
Cognitive style and depressionr Symptom-related, event-related or independent provoking factor? Br3
G Parry (1988)
Localised injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
MF Brin
10.3233/BEN-1990-3206
Body concept, disability, and depression in patients with spasmodic torticollis.
M. Jahanshahi (1990)
10.2307/2091308
Society and the adolescent self-image
M. Rosenberg (1966)
10.3233/BEN-1990-3403
A Longitudinal Follow-up Study of Depression, Disability, and Body Concept in Torticollis.
M. Jahanshahi (1990)
10.1002/MDS.870020402
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
M. Brin (1987)
Botulinum toxin in spasmodic torticollis.
J. Tsui (1988)
Classification and investigation of dystonia
A Barbeau
10.1001/ARCHPSYC.1961.01710120031004
An inventory for measuring depression.
A. Beck (1961)



This paper is referenced by
10.5772/INTECHOPEN.78360
Non-Motor Symptoms in Patients with Primary Dystonia
N. Semerdjieva (2018)
10.1002/mds.25790
Cognitive impairment in rapid‐onset dystonia‐parkinsonism
J. Cook (2014)
10.18203/2320-6012.ijrms20164023
Assessment of health related quality of life in patients with cervical dystonia and writer’s cramp -
P. Singh (2016)
10.1002/mds.23906
Obsessive‐compulsive symptoms in primary focal dystonia: A controlled study
B. Barahona-Corrêa (2011)
10.1111/ncn3.12344
A pilot study on efficacy and tolerability of cognitive behavioral therapy (CBT‐FD) for Japanese patients with focal dystonia
K. Kobayashi (2020)
10.1007/s00415-008-0020-x
Depression in focal, segmental and generalized dystonia
L. Lewis (2008)
10.1024/1016-264X/A000045
Primäre Dystonien – zwischen Botulinum Toxin-Behandlung, Neuropsychologie, Psychotherapie und Tiefer Hirnstimulation
B. Leplow (2011)
10.1016/S0272-7358(00)00056-8
Adjusting to disfigurement: processes involved in dealing with being visibly different.
A. Thompson (2001)
10.1136/jnnp.68.2.227
Factors that ameliorate or aggravate spasmodic torticollis
M. Jahanshahi (2000)
10.1007/BF00999994
EMG biofeedback treatment of torticollis: A controlled outcome study
M. Jahanshahi (1991)
10.1016/B978-012738903-5/50008-4
Botulinum Toxins: Transformation of a Toxin into a Treatment
Cynthia L. Cornelia (2005)
10.1212/WNL.49.3.701
Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
M. Lew (1997)
10.1002/mds.25501
Psychiatric comorbidities in dystonia: Emerging concepts
M. Zurowski (2013)
10.1007/978-3-642-18533-5_13
Dystone Störungen und psychische Beeinträchtigung am Beispiel der zervikalen Dystonie
H. Gündel (2004)
10.1002/mds.20055
Patient‐based outcomes of cervical dystonia: A review of rating scales
S. Cano (2004)
10.1136/jnnp.71.4.499
Social phobia in spasmodic torticollis
H. Guendel (2001)
10.1002/mds.10594
Posttraumatic painful torticollis
D. Sá (2003)
10.1007/S11940-999-0030-8
Cervical dystonia (torticollis)
M. Brin (1999)
10.3389/fpsyg.2016.01492
Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study
P. Perozzo (2016)
10.3109/9780203640487-24
Dystonia rating scales
S. Cano (2007)
The dystonias.
Reuban Pratheepan (1990)
10.1002/mds.21234
Quality of life in focal, segmental, and generalized dystonia
Donna Page (2007)
10.1038/s41598-020-69773-7
Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
T. Makunts (2020)
10.3109/9780203640487-23
Dystonia and quality of life
S. Cano (2007)
10.1111/j.1468-1331.2009.02884.x
Quality of sleep in primary focal dystonia: a case–control study
L. Avanzino (2010)
10.1007/s00415-003-0236-8
The clinical expression of primary dystonia
Alberto Albanese (2003)
Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
J. Slawek (2007)
10.2165/00019053-199712060-00009
Costs of Treating Dystonias and Hemifacial Spasm with Botulinum Toxin A
R. Dodel (2012)
10.2165/00003495-200262040-00011
Botulinum Toxin B
D. Figgitt (2012)
10.1016/S1388-2457(01)00478-3
Remote F-wave changes after local botulinum toxin application
K. Wohlfarth (2001)
10.1177/1756285612447261
Current and future medical treatment in primary dystonia
C. Delnooz (2012)
10.1136/JNNP.71.2.193
Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia.
R. Hilker (2001)
See more
Semantic Scholar Logo Some data provided by SemanticScholar